Human experimentation: a guided step into the unknown
Spectacular treatment disasters in recent years have made it clear that informal "let's-try-it-and-see" methods of testing new proposals are more risky now than ever before, and have led many to call for a halt to experimentation in clinical medicine. In this easy-tp-read, philosophical guide to human experimentation, William Silverman pleads for wider use of randomized clinical trials, citing many examples that show how careful trials can overturn preconceived or ill-conceived notions of a therapy's effectiveness and lead to a clearer understanding of clinical anomalies. Because it gives careful guidance on setting up trials and avoiding conceptual pitfalls, this book will be of great interest to all epidemiologists and clinical statisticians, and to a wide varitey of clinicians, pharmacologists, and nurses. Since it requires no medical or statistical knowledge, it will also appeal to ethicists, lawyers, and the general public.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Knowing in medicine
Framing the question
10 other sections not shown
Other editions - View all
approach argument assigned associations babies bedside behavior bias birthweight blindness calculation cancer cent chance compared concerning concurrent controls conducted controlled trial death decision Decision theory developed diagnostic difference disease disorder doctors drug effect enrolled estimate evaluate evidence examined example expected experience exposure formal frequency hospitals human experimentation hypothesis increase indicated informed consent innovation intervention investigators kilograms level of measurement life-table limits marbles measurement medicine ment method mortality number of patients observations occur occurrence of RLF outcomes oxygen treatment participants physicians placebo population possible practice premature infants probability problems procedure proportion question R.A. Fisher random allotment randomized clinical trial regimen relatively retrolental fibroplasia risk level RLF trial sample scale scientific spastic diplegia specified standard statistically significant stopping rule supplemental oxygen survey survival tions treated Type I error utility variables